Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 157
9
Diseases
17
Unique genes
0.258
Avg. similarity score
Caroli disease
Most-connected disease (5 links)
Disease
Searched: autosomal recessive polycystic kidney disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
autosomal recessive polycystic kidney disease
Caroli disease
Congenital hypoplasia of aortic arch
Cystathionine beta-synthase deficiency
Periportal fibrosis
Ventricular hypertrophy
Anhydramnios
Biliary-renal-neuro-skeletal syndrome
Homocystinuria
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Caroli disease | 5 | 5 | 4 |
| Congenital hypoplasia of aortic arch | 5 | 5 | 1 |
| Cystathionine beta-synthase deficiency | 5 | 5 | 2 |
| Periportal fibrosis | 5 | 5 | 1 |
| autosomal recessive polycystic kidney disease | 5 | 5 | 3 |
| Ventricular hypertrophy | 3 | 3 | 3 |
| Anhydramnios | 2 | 2 | 11 |
| Biliary-renal-neuro-skeletal syndrome | 1 | 1 | 1 |
| Homocystinuria | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| PKHD1 | 7 / 9 | Anhydramnios, autosomal recessive polycystic kidney disease, Caroli disease, Congenital hypoplasia of aortic arch and 3 more |
| PKD1 | 3 / 9 | Anhydramnios, autosomal recessive polycystic kidney disease, Caroli disease |
| CBS | 2 / 9 | Cystathionine beta-synthase deficiency, Homocystinuria |
| IFT56 | 2 / 9 | Biliary-renal-neuro-skeletal syndrome, Caroli disease |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Renin-angiotensin system | KEGG | 3 / 23 | 92.1× | 4.10e-6 | 1.74e-4 ✓ sig. |
| Renin secretion | KEGG | 3 / 69 | 30.7× | 1.17e-4 | 2.62e-3 ✓ sig. |
| Diabetic cardiomyopathy | KEGG | 4 / 205 | 13.8× | 1.65e-4 | 3.45e-3 ✓ sig. |
| Metabolism of Angiotensinogen to Angiotensins | Reactome | 2 / 17 | 83.1× | 2.53e-4 | 4.81e-3 ✓ sig. |
| Hypertrophic cardiomyopathy | KEGG | 3 / 99 | 21.4× | 3.40e-4 | 6.11e-3 ✓ sig. |
| VxPx cargo-targeting to cilium | Reactome | 2 / 21 | 67.3× | 3.90e-4 | 6.81e-3 ✓ sig. |
| Vascular smooth muscle contraction | KEGG | 3 / 134 | 15.8× | 8.24e-4 | 1.21e-2 ✓ sig. |
| Adrenergic signaling in cardiomyocytes | KEGG | 3 / 154 | 13.8× | 1.23e-3 | 1.65e-2 ✓ sig. |
| Cushing syndrome | KEGG | 3 / 155 | 13.7× | 1.26e-3 | 1.67e-2 ✓ sig. |
| Cortisol synthesis and secretion | KEGG | 2 / 65 | 21.7× | 3.72e-3 | 3.68e-2 ✓ sig. |
| Cysteine formation from homocysteine | Reactome | 1 / 3 | 235× | 4.24e-3 | 4.04e-2 ✓ sig. |
| Trafficking of myristoylated proteins to the cilium | Reactome | 1 / 5 | 141× | 7.06e-3 | 5.68e-2 |
| Aldosterone synthesis and secretion | KEGG | 2 / 98 | 14.4× | 8.28e-3 | 6.27e-2 |
| Negative feedback regulation of MAPK pathway | Reactome | 1 / 6 | 118× | 8.46e-3 | 6.37e-2 |
| AGE-RAGE signaling pathway in diabetic complications | KEGG | 2 / 101 | 14.0× | 8.77e-3 | 6.53e-2 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| kidney development | GO:0001822 | 8 / 146 | 60.2× | 2.62e-13 | 1.34e-10 ✓ sig. |
| maintenance of blood vessel diameter homeostasis by renin-angiotensin | GO:0002034 | 3 / 5 | 660× | 6.25e-9 | 1.13e-6 ✓ sig. |
| regulation of systemic arterial blood pressure by renin-angiotensin | GO:0003081 | 3 / 6 | 550× | 1.25e-8 | 2.07e-6 ✓ sig. |
| mesonephric duct development | GO:0072177 | 3 / 6 | 550× | 1.25e-8 | 2.07e-6 ✓ sig. |
| blood vessel diameter maintenance | GO:0097746 | 4 / 37 | 119× | 3.04e-8 | 4.47e-6 ✓ sig. |
| angiotensin-activated signaling pathway | GO:0038166 | 3 / 16 | 206× | 3.48e-7 | 3.54e-5 ✓ sig. |
| regulation of renal output by angiotensin | GO:0002019 | 2 / 2 | 1,099× | 7.79e-7 | 6.91e-5 ✓ sig. |
| regulation of vasoconstriction | GO:0019229 | 3 / 23 | 143× | 1.10e-6 | 9.11e-5 ✓ sig. |
| cilium assembly | GO:0060271 | 5 / 237 | 23.2× | 1.72e-6 | 1.32e-4 ✓ sig. |
| renin-angiotensin regulation of aldosterone production | GO:0002018 | 2 / 3 | 733× | 2.34e-6 | 1.69e-4 ✓ sig. |
| regulation of renal sodium excretion | GO:0035813 | 2 / 3 | 733× | 2.34e-6 | 1.69e-4 ✓ sig. |
| metanephric ascending thin limb development | GO:0072218 | 2 / 4 | 550× | 4.67e-6 | 2.92e-4 ✓ sig. |
| blood vessel remodeling | GO:0001974 | 3 / 42 | 78.5× | 7.02e-6 | 4.07e-4 ✓ sig. |
| branching involved in ureteric bud morphogenesis | GO:0001658 | 3 / 45 | 73.3× | 8.67e-6 | 4.84e-4 ✓ sig. |
| determination of liver left/right asymmetry | GO:0071910 | 2 / 6 | 366× | 1.17e-5 | 6.08e-4 ✓ sig. |